OSCR (STOCKS)
Oscar Health, Inc.
$13.619200
+0.739200 (+5.74%)
Prev close: $12.880000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Managed Health Care
- CEO
- Mark T. Bertolini
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,791.66M
- Employees
- 2,400
- P/E (TTM)
- -7.77
- P/B (TTM)
- 3.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $11.29B |
| Benefits Costs and Expenses | $11.50B |
| Costs And Expenses | $11.50B |
| Nonoperating Income/Loss | -$3.24M |
| Operating Expenses | $11.50B |
| Selling, General, and Administrative Expenses | $2.00B |
| Other Operating Expenses | $9.49B |
| Operating Income/Loss | -$210.34M |
| Income/Loss From Continuing Operations After Tax | -$243.75M |
| Income/Loss From Continuing Operations Before Tax | -$238.31M |
| Income Tax Expense/Benefit | $5.45M |
| Income Tax Expense/Benefit, Deferred | -$2.45M |
| Net Income/Loss | -$243.75M |
| Net Income/Loss Attributable To Noncontrolling Interest | $333.00K |
| Net Income/Loss Attributable To Parent | -$244.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$244.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.96 |
| Diluted Earnings Per Share | -$1.05 |
| Basic Average Shares | 768,710,000 |
| Diluted Average Shares | 785,136,000 |
| Assets | $5.75B |
| Current Assets | $3.76B |
| Noncurrent Assets | $1.98B |
| Fixed Assets | $83.42M |
| Other Non-current Assets | $1.90B |
| Liabilities | $4.72B |
| Current Liabilities | $3.98B |
| Noncurrent Liabilities | $742.06M |
| Equity | $1.03B |
| Equity Attributable To Noncontrolling Interest | $2.91M |
| Equity Attributable To Parent | $1.02B |
| Liabilities And Equity | $5.75B |
| Net Cash Flow From Operating Activities | $769.77M |
| Net Cash Flow From Operating Activities, Continuing | $769.77M |
| Net Cash Flow From Investing Activities | -$223.80M |
| Net Cash Flow From Investing Activities, Continuing | -$223.80M |
| Net Cash Flow From Financing Activities | $394.86M |
| Net Cash Flow From Financing Activities, Continuing | $394.86M |
| Net Cash Flow | $940.83M |
| Net Cash Flow, Continuing | $940.83M |
| Comprehensive Income/Loss | -$253.42M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $333.00K |
| Comprehensive Income/Loss Attributable To Parent | -$253.75M |
| Other Comprehensive Income/Loss | -$9.67M |